We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$14.6B
AUM Growth
-$3.14B
Cap. Flow
-$4.13B
Cap. Flow %
-28.38%
Top 10 Hldgs %
20.74%
Holding
1,655
New
313
Increased
216
Reduced
349
Closed
770

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$214M
2
MDT icon
Medtronic
MDT
+$123M
3
CHTR icon
Charter Communications
CHTR
+$97.9M
4
MRK icon
Merck
MRK
+$94M
5
ZTS icon
Zoetis
ZTS
+$91.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.1%
2 Technology 16.39%
3 Industrials 11.22%
4 Consumer Discretionary 9.86%
5 Financials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAVA icon
676
Endava
DAVA
$156M
$608K ﹤0.01%
+21,000
New +$563K
LHCG
677
DELISTED
LHC Group LLC
LHCG
$604K ﹤0.01%
+5,865
New +$549K
TRNO icon
678
Terreno Realty
TRNO
$7.49B
$601K ﹤0.01%
15,952
-442,951
-97% -$16.6M
AUTL
679
Autolus Therapeutics
AUTL
$562M
$597K ﹤0.01%
19,811
-15,789
-44% -$426K
HEI.A icon
680
HEICO Corp Class A
HEI.A
$37.2B
$597K ﹤0.01%
7,910
+435
+6% +$30K
SCHL icon
681
Scholastic
SCHL
$792M
$594K ﹤0.01%
+12,715
New +$546K
SNN icon
682
Smith & Nephew
SNN
$12.6B
$593K ﹤0.01%
15,983
-21,434
-57% -$773K
ARLO icon
683
Arlo Technologies
ARLO
$1.65B
$591K ﹤0.01%
+40,739
New +$762K
CMD
684
DELISTED
Cantel Medical Corporation
CMD
$589K ﹤0.01%
+6,394
New +$609K
CG icon
685
Carlyle Group
CG
$17.2B
$581K ﹤0.01%
25,752
-39,875
-61% -$938K
AFL icon
686
Aflac
AFL
$62.6B
$571K ﹤0.01%
12,133
+4,533
+60% +$207K
TM icon
687
Toyota
TM
$225B
$568K ﹤0.01%
+4,572
New +$578K
CBM
688
DELISTED
Cambrex Corporation
CBM
$566K ﹤0.01%
8,286
-192,983
-96% -$11.9M
BLDR icon
689
Builders FirstSource
BLDR
$8.04B
$560K ﹤0.01%
38,107
+16,055
+73% +$272K
IBTX
690
DELISTED
Independent Bank Group, Inc.
IBTX
$555K ﹤0.01%
+8,369
New +$571K
CNA icon
691
CNA Financial
CNA
$14.1B
$552K ﹤0.01%
+12,094
New +$559K
IPGP icon
692
IPG Photonics
IPGP
$3.84B
$552K ﹤0.01%
+3,539
New +$657K
DEI icon
693
Douglas Emmett
DEI
$1.96B
$547K ﹤0.01%
14,500
-150,402
-91% -$5.86M
EGP icon
694
EastGroup Properties
EGP
$10.9B
$545K ﹤0.01%
+5,703
New +$548K
SAIC icon
695
Saic
SAIC
$5.35B
$544K ﹤0.01%
6,757
-2,068
-23% -$176K
CLR
696
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$539K ﹤0.01%
+7,900
New +$499K
AGCO icon
697
AGCO
AGCO
$7.2B
$530K ﹤0.01%
+8,721
New +$528K
AXTA icon
698
Axalta
AXTA
$8.17B
$530K ﹤0.01%
18,166
+7,721
+74% +$232K
MU icon
699
Micron Technology
MU
$991B
$530K ﹤0.01%
11,721
-455,758
-97% -$23M
NGG icon
700
National Grid
NGG
$81.3B
$519K ﹤0.01%
11,317
-115,244
-91% -$5.48M

Similar funds

Marshall Wace North America's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace North America held 1,655 positions worth $14.6B, down 18% from $17.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Marshall Wace North America withdrew a net $4.13B in Q3 2018, closing 770 positions and reducing 349 holdings. Its most notable exit was Baidu, an estimated $120M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Marshall Wace North America opened a new position in Medtronic worth $130M.

  • Marshall Wace North America's largest Q3 2018 buy was Medtronic: 1,325,878 shares worth $130M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q3 2018, an estimated $214M increase.
  • Marshall Wace North America's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $253M.
  • Marshall Wace North America fully exited Baidu in Q3 2018, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 21% of its $14.6B portfolio in Q3 2018.
  • Marshall Wace North America opened 313 new positions and closed 770 in Q3 2018.
  • Marshall Wace North America's portfolio value fell 18% quarter-over-quarter to $14.6B.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.